Black-Box Warnings of Antiseizure Medications: What is Inside the Box? Abdul WahabAttiya Iqbal Review Article 29 April 2023 Pages: 233 - 250
Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond Lisa GieberVincent Muturi-KioiAyesha Sitlani Current Opinion 28 April 2023 Pages: 203 - 214
A Science-Based Methodology Framework for the Assessment of Combination Safety Risks in Clinical Trials Andriani C. PateraJulie MaidmentKen Twomey Current Opinion Open access 26 April 2023 Pages: 183 - 202
How Digital Opinion Leaders (DOLs) in Clinical Care are Changing the Medical Landscape Khoi ThanLori Salamida Leading Article 23 April 2023 Pages: 215 - 220
Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities Neil McAuslaneMagda BujarStuart Walker Original Research Article 19 April 2023 Pages: 251 - 260
Value and Implementation of the Aggregate Safety Assessment Plan Barbara A. HendricksonAnupam AgarwalLothar Tremmel Current Opinion 19 April 2023 Pages: 171 - 181
Designing Clinical Trials to Assess the Impact of Pharmacological Treatment for Suicidal Ideation/Behavior: Issues and Potential Solutions Zhixing YaoWilliam V. McCall Review Article 13 April 2023 Pages: 221 - 232
Major Pharmaceutical Conferences and Courses: August to September 2023 Update 06 April 2023 Pages: 261 - 263
A Principles Framework for Digital Provision of Medical Information for Healthcare Professionals Susan MohamedSarah DunnettMILE (Medical Information Leaders in Europe) Current Opinion Open access 31 March 2023 Pages: 103 - 109
Effect of Caffeine Consumption on Cardiovascular Disease: An Updated Review Sajad KhialiAmin AgabalazadehTaher Entezari-Maleki Review Article 30 March 2023 Pages: 139 - 151
Medical Information Delivering Improved Customer Experience: A Guide Pete GuillotJohn SheaEvelyn R. Hermes-DeSantis Current Opinion Open access 05 April 2023 Pages: 111 - 119
Clinical Presentations of Drug-Induced Hyperprolactinaemia: A Literature Review Daniela R. JunqueiraDimitri BennettCarolina Casañas i Comabella Review Article Open access 17 February 2023 Pages: 153 - 166
Considerations for Effective Communication of Medical Information Eddie G. M. Power Current Opinion 14 February 2023 Pages: 97 - 101
Major Pharmaceutical Conferences and Courses: June to July 2023 Update 06 February 2023 Pages: 167 - 170
Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions Stuart D. FaulknerFabian SomersPaul Robinson Review Article 18 January 2023 Pages: 129 - 138
Digital Therapies (DTx) as New Tools within Physicians’ Therapeutic Arsenal: Key Observations to Support their Effective and Responsible Development and Use Jean-Christophe Bélisle-PiponPierre-Marie David Current Opinion 18 January 2023 Pages: 121 - 127
Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review Naohiko WakutsuEmi HiroseSven Demiya Systematic Review Open access 17 January 2023 Pages: 53 - 70
Major Pharmaceutical Conferences and Courses: April to May 2023 Update 07 January 2023 Pages: 93 - 96
Drug-Induced Gambling Disorder: Epidemiology, Neurobiology, and Management Mirjam WolfschlagAnders Håkansson Review Article Open access 07 January 2023 Pages: 37 - 52
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA) Lerato MoetiMadira LiteduJacques Joubert Original Research Article Open access 04 January 2023 Pages: 71 - 91
Somatic Gene Therapy Research in Pediatric Populations: Ethical Issues and Guidance for Operationalizing Early Phase Trials Alison Bateman-HouseLesha D. ShahCara Hunt Review Article 17 December 2022 Pages: 17 - 24
Evaluating Treatment Efficacy by Combining Multiple Measures in Clinical Trial Applications Abdullah Al MasudSamaradasa WeerahandiChing-Ray Yu Leading Article 02 December 2022 Pages: 7 - 16
The Future of Health and Science: Envisioning an Intelligent HealthScience System Martin S. KohnRebecca KushGreg Koski Editorial 02 December 2022 Pages: 1 - 6
The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes Farhang ModaresiKaivan Talachian Systematic Review 10 November 2022 Pages: 387 - 400
Major Pharmaceutical Conferences and Courses: February to March 2023 Update 08 November 2022 Pages: 401 - 403
Correction to: The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases Celine AertsEliana BarrenhoElisa Sicuri Correction Open access 07 November 2022 Pages: 405 - 405
The Effectiveness and Safety of Cannabidiol in Non-seizure-related Indications: A Systematic Review of Published Randomized Clinical Trials Yuni TangKolbi L. TonkovichToni Marie Rudisill Systematic Review 21 October 2022 Pages: 353 - 385
Potential Role of Polyphenolic Flavonoids as Senotherapeutic Agents in Degenerative Diseases and Geroprotection Kingsley C. MbaraNikita DevnarainPeter M. O. Owira Review Article 13 September 2022 Pages: 331 - 352
Major Pharmaceutical Conferences and Courses: December 2022 to January 2023 Update 12 September 2022 Pages: 319 - 321
Pricing and Market Access Challenges in the Era of One-Time Administration Cell and Gene Therapies Marco T. SabatiniTia XiaMark Chalmers Current Opinion 22 August 2022 Pages: 265 - 274
Medical Research Charities and Biopharmaceutical Companies as Partners in Patient-Centred R&D Tina FlatauJulie GreenfieldJohn Wise Current Opinion 12 August 2022 Pages: 279 - 286
The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature Maribel SalasJan PetracekTina Bostic Systematic Review 29 July 2022 Pages: 295 - 306
Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK Rajmeet JanduCarl NaraynassamyNadarajah Sreeharan Current Opinion 28 July 2022 Pages: 275 - 278
The Randomised Controlled Trial at the Intersection of Research Ethics and Innovation Torbjörn Callréus Leading Article 25 July 2022 Pages: 287 - 293
Utilizing Deep Learning for Detecting Adverse Drug Events in Structured and Unstructured Regulatory Drug Data Sets Benjamin M. KniselyQais HatimMonifa Vaughn-Cooke Original Research Article 24 July 2022 Pages: 307 - 317
Major Pharmaceutical Conferences and Courses: October to November 2022 Update 15 July 2022 Pages: 261 - 264
Potential Channeling Bias in the Evaluation of Cardiovascular Risk: The Importance of Comparator Selection in Observational Research Hu LiFrancis MawandaStephen Motsko Original Research Article Open access 04 July 2022 Pages: 247 - 259
A Structured Methodology to Assess Safety Signal Strength and Inform Causality Assessment Tim SullivanMagnus NordRichard P. Hermann Current Opinion Open access 04 July 2022 Pages: 215 - 222
Global Landscape of Benefit–Risk Considerations for Medicinal Products: Current State and Future Directions Max WaschbuschLisa RodriguezShuai S. Yuan Current Opinion 03 July 2022 Pages: 201 - 213
Evaluation of the Performance of the Gulf Cooperation Council Centralised Regulatory Review Process: Strategies to Improve Product Authorisation Efficiency and Quality Hajed M. HashanSarah K. Al-MutebStuart R. Walker Original Research Article Open access 29 June 2022 Pages: 223 - 231
An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach Clare LaveryJoanne EmmottLouise Woodward Original Research Article Open access 20 June 2022 Pages: 233 - 245
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice Ajeet GajraAbigail ZalenskiAnkit Kansagra Current Opinion Open access 07 June 2022 Pages: 163 - 171
Calling for Unity, Solidarity, Continuity, and Access-Oriented Action in Times of War Birgit R. BuergiThalia ArawiAleksander Wiśniewski Editorial Open access 02 June 2022 Pages: 147 - 151
The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases Celine AertsEliana BarrenhoElisa Sicuri Original Research Article Open access 19 May 2022 Pages: 189 - 197
Major Pharmaceutical Conferences and Courses: August to September 2022 Update 03 May 2022 Pages: 199 - 200
Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets Rani Lill AnjumRebecca E ChandlerElena Rocca Current Opinion Open access 29 April 2022 Pages: 153 - 161
Chaos to Clarity: Pragmatic Approaches to Overcome Challenges for Successful Implementation of Additional Risk Minimisation Measures in the European Union and the UK by a Marketing Authorisation Holder Kalindi HapaniNipa ParikhHarshil Patel Original Research Article 13 April 2022 Pages: 173 - 188